Biblio Discovery — Demo Discovery Service

5 results for "Soni, Prashant"

Showing 1–5 · 0.49 seconds · RSS

  1. Journal Article Full text

    Birth Asphyxia: Risk Factors, Complications, and Outcomes in Neonates Admitted at a Tertiary Care Center in Gujarat, India

    Soni, Hrishabh; Pandya, Nimisha; Soni, Prashant et al.

    Cureus · 2025 · English · PubMed Central

    Background Birth asphyxia is a significant cause of neonatal morbidity and mortality, especially in low- and middle-income countries. It is often associated with long-term neurological and systemic complications. This study explores the incidence, maternal and neonatal risk factors, and outcomes of…

  2. Journal Article Full text

    RNA-seq data of control and powdery mildew pathogen (Golovinomyces orontii) treated transcriptomes of Helianthus niveus

    Sujatha, Mulpuri; Ulaganathan, Kandasamy; Bhanu, Bhupatipalli Divya et al.

    Data Brief · 2018 · English · PubMed Central

    Identification of genes expressed during the Golovinomyces orontii infection process in Helianthus niveus assumes importance for incorporation of resistance to powdery mildew in cultivated sunflower (H. annuus L.) from this donor species. RNA-seq analysis of control (uninfected) and infected…

  3. Journal Article Full text

    P-1184. Efficacy and Safety of Imipenem/Cilastatin/Relebactam (IMI/REL) in Treating Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia: A Systematic Literature Review of Randomized Control Trials

    Cameron, Carolyn; Bagga, Shalini; Khurana, Vaneet Pal Kaur et al.

    Open Forum Infect Dis · 2026 · English · PubMed Central

    …I work for a consultancy that contracts with Pharma companies Prashant Soni, Masters in Pharmacy, BMS: I work in a consultancy that contracts with Pharma companies|Merck: I work in a consultancy that contracts with Pharma companies|Pfizer: I work in a consultancy that contracts with Pharma…

  4. Journal Article Full text

    Exploring the Effectiveness of Imipenem/Relebactam in Patients with Antimicrobial-Resistant Hospital-Acquired Infections: Findings from Systematic Literature Reviews

    Shields, Ryan K.; Martin-Loeches, Ignacio; Yücel, Emre et al.

    Antibiotics (Basel) · 2026 · English · PubMed Central

    Introduction: Infections attributed to multidrug-resistant organisms have resulted in a significant clinical burden, high mortality, and excessive costs. Identifying the most appropriate and efficacious treatments will aid in reducing these burdens. Imipenem/cilastatin + relebactam (I/R) is used…